SNN - Smith & Nephew plc
| Previous Close | 46.34 |
| Open | 46.68 |
| Bid | 46.54 x 800 |
| Ask | 46.56 x 800 |
| Day's Range | 46.53 - 46.67 |
| 52 Week Range | 32.22 - 47.05 |
| Volume | 19,225 |
| Avg. Volume | 435,642 |
| Market Cap | 20.401B |
| Beta (3Y Monthly) | 0.13 |
| PE Ratio (TTM) | 29.22 |
| EPS (TTM) | 1.59 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.72 (1.54%) |
| Ex-Dividend Date | 2019-04-04 |
| 1y Target Est | 52.00 |
- GuruFocus.com
Gains in Knee Replacement Driving Zimmer Biomet Growth
Shares near 52-week high after surpassing 2nd-quarter expectations Continue reading...
- Simply Wall St.
Should Smith & Nephew plc's (LON:SN.) Recent Earnings Decline Worry You?
Examining how Smith & Nephew plc (LON:SN.) is performing as a company requires looking at more than just a years...
- MoneyShow
Smith Nephew SNN- 2019 Top Picks' Mid-Year Update
Nancy Zambell, editor of Wall Street's Best Investments, chose Smith & Nephew plc (SNN) as her top conservative investment idea for 2019. The stock rose 16.5% in the first half of the year. Here's her latest update on the healthcare firm.
- Simply Wall St.
Will Smith & Nephew plc's (LON:SN.) Earnings Grow Over The Next Year?
Looking at Smith & Nephew plc's (LON:SN.) earnings update in December 2018, it seems that analyst forecasts are fairly...
- PR Newswire
Smith & Nephew meniscal knee repair technology delivers 0% re-operation rate and 100% meniscal healing at six months shows first ever study of horizontal cleavage tears
LONDON , July 11, 2019 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the results of the first ever prospective clinical trial to evaluate ...
- Zacks
Smith & Nephew Acquires Atracsys, Expands Robotic Portfolio
With Smith & Nephew's (SNN) buyout of Atracsys, the latter's fusionTrack 500 optical tracking camera will be a core enabling technology for the company's next-generation robotics platform.
- Simply Wall St.
Despite Its High P/E Ratio, Is Smith & Nephew plc (LON:SN.) Still Undervalued?
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...
- Simply Wall St.
Estimating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)
Does the June share price for Smith & Nephew plc (LON:SN.) reflect what it's really worth? Today, we will estimate the...
- Insider Monkey
Here’s What Hedge Funds Think About Smith & Nephew plc (SNN)
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the first quarter. One of these stocks was Smith & Nephew plc (NYSE:SNN). Smith & Nephew plc (NYSE:SNN) […]
- Simply Wall St.
Need To Know: Smith & Nephew plc (LON:SN.) Insiders Have Been Selling Shares
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
- American City Business Journals
DHL plans to add 50 jobs, invest millions of dollars in Memphis facilities
Logistics firm DHL Supply Chain will expand its medical device and pharmaceutical logistics business in Memphis, bringing about 50 more jobs and $8 million in capital investment.
- Zacks
Smith & Nephew (SNN) Buys Brainlab, Braces Robotic Ecosystem
The transaction by Smith & Nephew (SNN), besides the business purchase, comprises certain intangible assets and the orthopaedic Brainlab salesforce.
- Zacks
Titan Medical (TMDI) Shows Promise on Strategic Developments
Titan Medical (TMDI) is putting in a good deal of effort to strengthen its position in the multi-billion dollar computer-assisted robotic surgical technologies market.
- Reuters
INSIGHT-Will Europe's clampdown on faulty medical devices hurt patients?
When a Californian company founded by a U.S. veteran wounded in Afghanistan sought to register a new medical device this year, it turned to Europe before the United States. "Now it has flipped," said Bill Colone, CEO of San Clemente-based Spinal Singularity, which hopes to launch a 'smart' catheter for men with spinal injuries or disease early next year after squeezing in its application under the old European rules. Colone is part of a chorus of industry voices warning that a switch to stricter European rules governing medical devices, due to come into force a year from now, will slow or even halt the release of products in Europe that could transform patients' lives.
- PR Newswire
Smith & Nephew Launches the CONQUEST FN™ Femoral Neck Fracture System, a Fresh Approach to Hip Preservation Versus Current Treatment Options
LONDON , June 5, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, has announced the launch of its CONQUEST FN™ system, a new implant solution to treat femoral ...
- Simply Wall St.
Do Directors Own Smith & Nephew plc (LON:SN.) Shares?
A look at the shareholders of Smith & Nephew plc (LON:SN.) can tell us which group is most powerful. Insiders often...
- PR Newswire
Smith & Nephew's OXINIUM™ Technology for Hips could save the US Health System an estimated $296 Million in 2020
LONDON , May 22, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today presented new data at the International Society for Pharmacoeconomics and Outcomes ...
- Simply Wall St.
How Good Is Smith & Nephew plc (LON:SN.), When It Comes To ROE?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
- PR Newswire
Smith & Nephew launches new FLOW 90™ Wand at ISAKOS joining its innovative collection of COBLATION™ technology and shoulder repair portfolios
LONDON , May 13, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the U.S. launch of the WEREWOLF™ FLOW 90 Wand with FLOW~IQ™ Technology. ...
- Business Wire
New NICE guidance recognises that Smith & Nephew’s PICO™ sNPWT provides better outcomes than standard dressings in patients at high risk of surgical site infections, at similar overall cost
Smith & Nephew , the global medical technology business, welcomes the launch of new medical technologies guidance from the UK National Institute for Health and Care Excellence .
- Reuters
Smith & Nephew lifts revenue view after best quarter since 2015
Emerging markets, especially China, have been a bright spot for the company as its mature markets, including the United States which accounts for about half of its revenue, stabilise after a shaky start to last year. Growth of 15.3 percent in emerging markets powered Smith & Nephew's total revenue to $1.20 billion (£919.4 million), in line with analysts' expectations, according to a company-compiled consensus http://www.smith-nephew.com/investor-centre/reporting/analyst-consensus. Demand from emerging markets will continue to lift the company as patient populations grow and medical expertise improves, Chief Executive Officer Namal Nawana told Reuters.
